Term Name: | D-lysyl-N-(2-{[(2R)-1-phenylpropan-2-yl]amino}ethyl)glycinamide |
---|---|
Synonyms: | (2R)-2,6-diamino-N-{2-oxo-2-[(2-{[(2R)-1-phenylpropan-2-yl]amino}ethyl)amino]ethyl}hexanamide, (R)-2,6-diamino-N-(2-oxo-2-((2-(((R)-1-phenylpropan-2-yl)amino)ethyl)amino)ethyl)hexanamide, D-lysyl-N-(2-{[(2R)-1-phenylpropan-2-yl]amino}ethyl)glycinamide |
Definition: | A secondary carboxamide resulting from the formal condensation of the carboxy group of D-lysylglycine with the primary amino group of N-[(2R)-1-phenylpropan-2-yl]ethane-1,2-diamine. It is a hapten used in the development of an anti-methamphetamine vaccine. |
Ontology: | ChEBI [CHEBI:233672] ( EBI ) |